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Transthyretin (TTR) is a carrier protein involved in human amyloidosis. The development of small mol-
ecules that may act as TTR amyloid inhibitors is a promising strategy to treat these pathologies. Here
we selected and characterized the interaction of ﬂavonoids with the wild type and the V30M amyloido-
genic mutant TTR. TTR acid aggregation was evaluated in vitro in the presence of the different ﬂavonoids.
The best TTR aggregation inhibitors were studied by Isothermal Titration Calorimetry (ITC) in order to
reveal their thermodynamic signature of binding to TTRwt. Crystal structures of TTRwt in complex with
the top binders were also obtained, enabling us to in depth inspect TTR interactions with these ﬂavo-
noids. The results indicate that changing the number and position of hydroxyl groups attached to the ﬂa-
vonoid core strongly inﬂuence ﬂavonoid recognition by TTR, either by changing ligand afﬁnity or its
mechanism of interaction with the two sites of TTR. We also compared the results obtained for TTRwt
with the V30M mutant structure in the apo form, allowing us to pinpoint structural features that may
facilitate or hamper ligand binding to the V30M mutant. Our data show that the TTRwt binding site is
labile and, in particular, the central region of the cavity is sensible for the small differences in the ligands
tested and can be inﬂuenced by the Met30 amyloidogenic mutation, therefore playing important roles in
ﬂavonoid binding afﬁnity, mechanism and mutant protein ligand binding speciﬁcities.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Aggregation and deposition of transtyretin (TTR) and its vari-
ants are involved in several severe amyloid diseases, such as senile
systematic amyloidoses (SSA), familial amyloid polyneuropathy
(FAP), familial amyloid cardiomyopathy (FAC) and central nervous
system amyloidoses (CNSA). SSA is characterized by wild type TTR
(TTRwt) amyloid deposits (Connors et al., 2000; Westermark et al.,
1990), whereas more than a hundred TTR point mutants are asso-
ciated with FAP, FAC and CNSA (Connors et al., 2000). The V30M
variant is the most prevalent cause of FAP and the mutation causes
decreased tetramer stability, resulting in much more extensive TTR
aggregation that accelerates the onset of FAP (Quintas et al., 1999).0M, Val30Met mutant; TTBS,
API, apigenin; LUT, luteolin;
ﬁsetin; QUE, quercetin; BAI,
ica, Universidade de Campi-
B. Trivella).
evier OA license.TTR is a homo-tetrameric b-sheet-rich protein involved in the
transport of the retinol-binding protein (RBP) and the thyroid hor-
mone T4 in human plasma and cerebral spinal ﬂuid (Bartalena and
Robbins, 1993). The tetramer is formed by subunits termed A, B, C
and D. Each subunit is composed of 127 amino acids and has a
molecular mass of 14 kDa.
Two TTR thyroxine binding sites (TBS) are located at the dimer–
dimer interface, between the inner sheets of two TTR dimers. These
TBS have a funnel-shaped morphology, with polar residues placed
at the entrance and the bottom and a hydrophobic core located at
the center. Three small depressions in TTR TBS are found and are
responsible for accommodating the iodine atoms of T4. These
depressions are termed halogen binding pockets (HBPs) 1, 2 and
3. HBP1 is formed by TTR residues Lys15, Leu17, Thr106, Ala108
and Val121 at the TBS entrance. HBP2 is deﬁned by Lys15, Val16,
Leu17, Ala108, Ala109 and Leu110 at the center of the cavity;
whereas HBP3 contains Leu17, Ala108, Ala109, Leu110, Ser117,
Thr118 and Thr119, and is at the bottom of TTR TBS.
The TTR TBS is capable of accommodating several classes of
chemicals including hormones and hormones analogues (Klabunde
et al., 2000;Morais-de-Sa et al., 2004; Oza et al., 2002; Petrassi et al.,
144 D.B.B. Trivella et al. / Journal of Structural Biology 180 (2012) 143–1532005; Trivella et al., 2011; Wojtczak et al., 1992; Wojtczak et al.,
1996; Zanotti et al., 1995), ﬂavonoids (Green et al., 2005; Trivella
et al., 2010) and non-steroidal anti-inﬂammatory drugs and their
analogues, that interact in distinct manners with the polar and
hydrophobic residues from TTR (Andricopulo et al., 2010; Klabunde
et al., 2000; Oza et al., 2002; Petrassi et al., 2005), albeit with low
speciﬁcity (Lima et al., 2010). Several bi-aryl and fused ring system
derived compounds were reported as potent TTR inhibitors (John-
son et al., 2008a,b, 2009). In addition, directed linked bi-aryl TTR
amyloid inhibitors were found as the most selective compounds
to TTR in comparison to the off targets COX and thyroid hormone
receptor (Johnson et al., 2008a), turning this class of compounds
interesting targets for TTR amyloidosis drug development.
TTR amyloid inhibitors display high afﬁnity for TTRwt and pro-
mote tetramer stabilization (Hammarstrom et al., 2003), which de-
lays TTR aggregation and ﬁbril formation, and are currently under
investigation as potential inhibitors of TTR ﬁbrosis and associated
amyloid diseases (Connelly et al., 2010; Johnson et al., 2005b; Ju-
lius and Hawthorne, 2008; Klabunde et al., 2000; Oza et al.,
2002; Petrassi et al., 2005).
TTR ligands can interact with the two TTR TBS following coop-
erative or non-cooperative binding mechanisms (Andrea et al.,
1980; Cheng et al., 1977; Johnson et al., 2005a). In the last years,
we have studied, using structural and thermodynamic approaches,
the molecular basis of TTR interactions with small molecules (Triv-
ella et al., 2011, 2010). Our ﬁndings pinpointed structural changes
in TTR tetramers and ligand features that may account for TTR allo-
sterism. Comparing the binding of T4 and T4 analogues, which act
by distinct mechanisms of interaction with TTR, it was possible
to predict ligand features and interactions responsible for TTR allo-
sterism in this class of TTR amyloid inhibitors (Trivella et al., 2011).
We also reported that subtle changes in TTRwt tetramer are
responsible for the cooperative mechanism of genistein binding
to TTRwt and that alterations induced by the V30M mutation
may interfere in the V30M mutant biding to this isoﬂavone (Triv-
ella et al., 2010). However, it is not entirely clear the origin of
the changes caused by genistein and if the observed conforma-
tional changes of the bottom of the binding cavity apply and also
inﬂuence the binding of other ﬂavonoids to TTR.
Aiming to better understand the mechanisms that guide TTR
interaction with ﬂavonoids, here we report the study of TTR inter-Fig. 1. Flavonoids: (A) general formula and (Bactions with several ﬂavonoids (Fig. 1), to probe the inﬂuence of
the number and position of hydroxyl groups in ﬂavonoid scaffold
compounds, as well as the B ring position, in their binding to TTR
and amyloid inhibition. Both TTRwt and the most frequent TTR
amyloidogenic variant, the V30M TTR mutant were studied in this
work. We gain insights into the molecular and thermodynamic ba-
sis of these interactions using isothermal titration calorimetry and
X-ray crystallography.
We also compared the results obtained to the wild type protein
with the V30M mutant structure in the apo form and in complex
with other ligands, which allowed us to propose structural features
in the ligands that may facilitate or hamper their binding to the
V30M mutant. These ﬁndings complement our previous results
with genistein and T4 analogues, allowing better understanding
of TTR interactions with inhibitors.2. Methods
2.1. Chemicals
Flavonoids were purchased from Sigma–Aldrich; columns and
resins were from GE Health Care; and crystallization kits were
from Hampton Research. All chemicals used in the experiments
were of reagent grade quality.
2.2. Protein expression and puriﬁcation
Recombinant TTRwt and the V30M variant were expressed and
puriﬁed as described previously (Lai et al., 1996). Protein concen-
trations were determined by using the absorption extinction coef-
ﬁcient of 7.76  104 M1 cm1 at 280 nm. Protein quality was
accessed by native gel electrophoresis (Phast system – GE Health-
care) and dynamic light scattering (DynaPro – Protein Solutions)
prior to experiments.
2.3. TTR acid-mediated aggregation assay
In vitro acid-mediated aggregation assays were carried out fol-
lowing well-established protocols (Green et al., 2005; Petrassi
et al., 2005; Trivella et al., 2010). Aggregation curves were) ﬂavonoids selected in the present study.
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to 57.6 lM and TTR concentration of 7.2 lM. Turbidity measure-
ments (absorbance at 400–600 nm) were used to determine the
relative aggregation RA of TTR at each ligand concentration in com-
parison to apoTTRwt (RA = Abs TTR:ligand/Abs apoTTRwt) and the
results were expressed as relative inhibition (RI = 1–RA). Experi-
ments were performed in triplicate and a blank group (without
TTR in the well assay) was always performed to take into account
the ligand absorbance in the chosen wavelength at the same exper-
imental conditions. The relative TTR aggregation curves were ﬁtted
using the dose response equation in the GraphPad Prism Software
(version 4.0, GraphPad). The IC50 values were extracted from these
calculations.2.4. Isothermal titraion calorimetry
ITC experiments were performed according to previously de-
scribed protocols (Green et al., 2005; Trivella et al., 2011, 2010).
Flavonoids (150 lM) were titrated into the ITC (VP-ITC – Microcal)
cell containing TTR (8–10 lM). Protein and ligand containing solu-
tions were prepared in the same buffer (25 mM Tris, 100 mM KCl,Table 1
X-ray data collection and process statistics for the TTRwt:LUT and TTRwt:API crystal
complexes. Numbers in parentheses denote values in the highest resolution shell.
Parameter/crystal structure TTRwt:LUT TTRwt:API
Wavelength (Å) 1,46 1,46
Spatial group P21212 P21212
Unit cell (Å) 43.26, 84.78, 65.09 43.15, 85.13, 64.46
Resolution range (Å) 26.01–1.90 21.49–1.90
High resolution range (Å) 2.00–1.90 1.95–1.90
Reﬂections on the working set 18244 (2386) 16740 (1031)
Reﬂections on the test set 987 (115) 964 (65)
R-factor* 18.35 (21.44) 18.93 (25.80)
R-free** 19.90 (23.96) 23.52 (31.15)
Completeness (%) 98.45 (92.00) 96.30 (77.57)
Redundancy 3.9 (3.5) 5.1 (3.7)
Average I/r 17.25 (2.5) 17.64 (3.48)
RMS bond (Å) 0.036 0.014
RMS angles () 1.62 1.42
Average B-factor (Å2) 23.63 27.00
Ramachandran outliers 0/229 0/229
* R-factor = Rhkl|(|Fo|–|Fc|)|/R(Fo), for the working set, corresponding to 95% of the
data.
** R-free = Rhkl|(|Fo|–|Fc|)|/R(Fo), for the test set, corresponding to 5% of the data.
Table 2





Unit cell (Å) 43.33, 85.67, 64.35
Resolution range (Å) 30.00–2.05
High resolution range (Å) 2.14–2.05
Reﬂections on the working set 14172 (1749)
Reﬂections on the test set 1184 (154)
R-factor* 21.20 (22.57)
R-free** 22.30 (26.71)
Completeness (%) 98.28 (99.00)
Redundancy 4.5 (4.6)
Average I/r 13.66 (4.00)
RMS bond (Å) 0.036
RMS angles () 1.80
Average B-factor (Å2) 25.48
Ramachandran outliers 0/229
* R-factor = Rhkl|(|Fo|–|Fc|)|/R(Fo), for the working set, corresponding to 95% of the dat
** R-free = Rhkl|(|Fo|–|Fc|)|/R(Fo), for the test set, corresponding to 5% of the data.1 mM EDTA and 5% DMSO; pH 8.0). Each experiment was per-
formed at 25 C with a preliminary injection of 2 lL followed by
59 injections of 5 lL at 4-min intervals. The heat of dilution, mea-
sured by the injection of the ligands into the same buffer assay
solution, was subtracted from each titration to obtain the net reac-
tion heat value. Data were recorded and analyzed using ORIGIN (v.
7, ORIGINLab) software.
ITC curves were ﬁtted using different binding modes available
in ORIGIN software and each result obtained was analyzed individ-
ually as will be discussed in the ‘results’ and ‘discussion’ sections.2.5. Crystallization
Prior to crystallization, TTR (85 lM) in 25 mM Tris, 100 mM KCl,
and 1 mM EDTA, pH 8.0 was incubated for at least 2 h in the pres-
ence of the selected ﬂavonoids (ﬁnal concentration 0.5–1 mM).
TTR:ligand co-crystals were grown in 2-lL hanging drops equili-
brated against 0.2 M CaCl2, 0.1 M HEPES pH 7.5–8.5, and PEG 400
(20–30%). Crystals appeared after 3 days and had about 0.1–
0.3 mm in their longest dimension.2.6. X-ray diffraction data collection and structure determination
The X-ray diffraction data collection was performed at the MX-2
beamline of the Brazilian National Synchrotron Light Laboratory
(LNLS, Campinas, Brazil) (Guimaraes et al., 2009) using synchrotron
radiation of wavelength 1.459 Å to optimize crystal diffraction efﬁ-
ciency and the synchrotron-radiation ﬂux of the LNLS storage ring
(Polikarpov et al., 1998). The diffraction images were registered on
a MAR225 mosaic detector, with an oscillation of 1 per image.
Data reduction was performed using iMOSFLM/SCALA (Leslie,
1999, 2006). Data collection statistics are given in Tables 1 and 2.
The X-ray structure of apoTTRwt (PDB ID: 3CFM), chains A and
B together, without water molecules, was used as an initial model
for molecular replacement using the program PHASER [35]. The
initial protein atomic model was subjected to rigid body reﬁne-
ment using chains A and B as independent rigid body domains in
REFMAC (Murshudov et al., 1997). The model was improved
through alternated cycles of real space reﬁnement using COOT
(Emsley and Cowtan, 2004), maximum likelihood minimization
using PHENIX (Adams et al., 2010) and tls plus restrained reﬁne-
ment using REFMAC5 (Murshudov et al., 1997). Ligands and water




43.73, 85.17, 65.06 42.48, 83.29, 65.54
22.25–1.60 19.27–1.75
1.65–1.60 1.79–1.75
27878 (2544) 20396 (1522)
1507 (138) 1136 (74)
18.93 (17.14) 19.53 (27.80)
21.33 (25.63) 22.61 (32.50)
89.48 (99.80) 98.13 (94.94)
5.1 (5.2) 4.8 (4.6)
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residues found in favorable regions of the Ramachandran plot.2.7. Crystal structure analysis
Protein:ligand contacts were analyzed using the LIGPLOT soft-
ware (Wallace et al., 1995), followed by visual inspection using
the program COOT (Emsley and Cowtan, 2004). A hydrogen bond
distance cutoff of 3.4 Å was applied. Superposition of apoTTR with
holoTTR structures was performed using the Superpose software
(CCP4, 1994).
To better understand the mechanistic details of possible open-
ing/closing movements of the binding channels caused by ﬂavo-
noid binding, we compared the two ligand–binding cavities (TTR
residues 14–17, 106–110 and 117–121) of the TTR tetramer in dif-
ferent TTR structures in both the apo and holo forms. The crystal
structures of TTRwt in complex with genistein (PDB ID 3KGU), apo-
TTRwt (PDB ID 3CFM), apoV30M (PDB ID 3KGS) and V30M in com-
plex with genistein (PDB ID 3KGT) were used. The volumes of the
binding cavities were calculated using the CASTp server (Dundas
et al., 2006), and equivalent Ca interatomic distances were mea-
sured according to the method of Neumann and co-workers (Neu-
mann et al., 2001). The water and ligand molecules found in the
binding cavities were excluded from these calculations.2.8. Coordinates
The atomic coordinates and structure factors of the TTRwt:LUT,
TTRwt:API, TTRwt:KAE, TTRwt:NAR and TTRwt:CHR crystal struc-
tures reported here were deposited to the Protein Data Bank under
codes 4DEW, 4DER, 4DET, 4DEU and 4DES, respectively.Table 3
Experimental and calculated parameters of TTRwt and V30M mutant TTR acid
mediated aggregation curves, conducted in the presence of the different ﬂavonoids
tested. Genistein and the natural ligand T4 were also included in the analysis for
comparison. TTR concentration used in the incubation was 7.2 lM, further diluted to
3.6 lM (physiological concentration) upon acidiﬁcation. Ligand concentration ranged
from 0 to 57.6 lM in the pre incubation. At least 6 concentration points were used.
Experiments were conducted in triplicates.
Ligand IC50 (lM)b ± r2a
TTRwt
T4 4.34 1.20 0.969
GEN 8.11 1.07 0.994
API 10.30 1.08 0.995
LUT 6.38 1.17 0.969
KAE 8.26 1.06 0.996
QUE 13.34 1.07 0.995
BAI 18.58 1.07 0.994
CHR 12.16 1.08 0.994
FIS 27.35 1.10 0.981
NAR 12.39 1.16 0.973
V30M
T4 7.14 1.08 0.995
GEN 11.46 1.08 0.991
API 8.28 1.10 0.989
LUT 5.68 1.10 0.992
KAE 14.55 1.09 0.989
QUE 17.99 1.07 0.990
BAI 65.92 1.09 0.967
CHR 37.24 1.06 0.991
FIS 86.90 1.03 0.994
NAR 21.83 1.09 0.988
a Non-linear ﬁt parameter for adjustment of the aggregation curves with the dose
response equation in the GraphPad software (v. 4.0; GraphPAD, San Diego).
b Ligand concentration equivalent to 50% TTR ﬁbril formation inhibition in the
adjusted curves.3. Results
3.1. TTR acid mediated aggregation assays
Commercial available ﬂavonoids were selected and tested for
inhibition of TTR aggregation in an acid mediated aggregation as-
say, using different concentrations of the tested ligands. Table 3
shows the IC50 values extracted from the aggregation curves. For
comparison, TTR aggregation curves were also conducted in the
presence of the natural ligand T4 or in the presence of the isoﬂav-
one genistein (GEN), a known TTR aggregation inhibitor (Green
et al., 2005; Trivella et al., 2010).
Within the tested set of compounds, LUT was the ﬂavonoid that
has a highest inhibitory potency against TTR aggregation in vitro. In
particular, the V30M inhibition by LUT (IC50 LUT = 5.68 ± 1.10 lM)
was even more pronounced (or equal, considering the error
bars) than that observed for the natural ligand T4 (IC50
T4 = 7.14 ± 1.08 lM). These results show that LUT is a potent
V30M amyloidogenic TTR inhibitor. API, which differs from LUT
by the absence of the hydroxyl group at the 30 position, was also
a potent inhibitor of both the TTRwt and the V30M mutant,
however with IC50 values slightly higher than the ones presented
by LUT (Table 3). The ﬂavonol KAE showed IC50 values similar
to those presented by GEN, LUT and API when inhibiting the
TTRwt (IC50 KAE TTRwt = 8.26 ± 1.06 lM). However, KAE showed
moderated potency when incubated with the V30M mutant
(IC50 KAE V30M = 14.55 ± 1.09 lM). Similarly, the other tested
ﬂavonoids (QUE, BAI, FIS and NAR) showed much lower potency
to the V30M mutant when compared to the wild type protein
(Table 3).
3.1.1. Isothermal titration calorimetry (ITC)
To further evaluate TTR interaction with the ﬂavonoids we also
conducted ITC assays. The TTRwt ITC curves are shown in Fig. S1
and the parameters extracted form these experiments are given
in Table 4.
The experimental curves were analyzed using different binding
equations available in Origin software (v. 7, Origin Lab), which ac-
count to cooperative and non-cooperative ligand binding to the
two sites of TTRwt. ITC curves with API and LUT were well de-
scribed by the ‘‘identical and independent’’ binding sites equation
only. However, the ITC curves of TTRwt binding to KAE, NAR or CHR
could be described either by the ‘‘identical and independent’’ or by
the ‘‘sequential’’ binding mode equations, with very similar statis-
tical parameters (Table 4). Therefore, the thermodynamic parame-
ters extracted in both ﬁts were stored and compared to other
experimental data reported here and we will return to this point
later on this article.
3.2. Crystal structures
Aiming at better understand TTR interaction with the selected
ﬂavonoids, we solved the X-ray crystal structures of the TTRwt
complexes with LUT, API, CHR, KAE and NAR.
The crystal structures of TTRwt complexes with ﬂavonoids be-
long to the P21212 space group with the asymmetric unit com-
posed by a dimer (chains A and B), with each chain containing
the amino acid residues from Cys10 to Asn124. The functional
TTR tetramer is generated by applying the two fold symmetry
operation on the Z axis. Since the two fold axis cross the two TTR
ligand binding sites exactly in the middle, two symmetrically re-
lated ligands are found in each binding site as already reported
(Klabunde et al., 2000; Trivella et al., 2011, 2010). For this reason,
ﬂavonoid molecules were initially reﬁned with occupancy of 0.5.
In all the ﬁve TTR:ﬂavonoids crystal structures reported here
the ligand is positioned with its B ring turned to the bottom
Table 4
Thermodynamic parameters of API, LUT, CHR, KAE and NAR interaction with the wild type TTR. Data were obtained from the adjustment of the ITC curves with binding equations
available in Origin software (v. 7, Origin Lab): identical and independent binding sites or sequential binding sites.
Ligand Model Kd (lM)a DG (kcal mol1)b DH (kcal mol1)a TDS (kcal mol1)b
LUT Independent 0.10 ± 0.01 9.53 10.30 ± 0.52 0.77
API Independent 0.49 ± 0.13 8.59 8.30 ± 0.24 0.29
CHR Independent 1.40 ± 0.06 7.98 8.89 ± 0.13 0.92
CHR Sequential 1.78 ± 0.63 7.83 10.00 ± 0.82 2.18
2.72 ± 0.39 7.58 9.86 ± 1.04 2.28
NAR Independent 2.29 ± 0.18 7.69 11.30 ± 0.94 3.62
NAR Sequential 0.61 ± 0.25 8.47 10.40 ± 0.59 1.96
4.82 ± 0.07 7.25 10.60 ± 1.15 3.36
KAE Independent 2.10 ± 0.63 7.74 9.63 ± 1.12 1.89
KAE Sequential 0.18 ± 0.05 9.19 8.15 ± 0.38 1.04
4.01 ± 0.97 7.35 7.58 ± 0.74 0.23
a Directed extracted from the experiment.
b Calculated from the average values of DH e Kd: bDG = RT ln(Kb); cDG = DH–TDS.
D.B.B. Trivella et al. / Journal of Structural Biology 180 (2012) 143–153 147portion of the TBS, whereas the A and C rings (Fig. 1A) occupy the
entrance of the cavity. The binding sites and ligand molecules
found in each structure are presented in Figs. 2 and 3.Fig. 2. Stereo view of the TTRwt:LUT (A), TTRwt:API (B) and TTRwt:CHR (C) binding sites,
since it was not observed differences between the AC and BD binding sites in these crys
shown as sticks and labeled. Water molecules that participate in binding are displayed as
The ligand is shown as sticks, contoured by the calculated omit map (2Fo–Fc) at r = 0.5.
cross the binding site vertically. The symmetric ligand copy is shown as grey sticks. The l
at the BD site of each crystal complex (in black). This superposition is shown in the right s
Figures were generated using the Pymol software (Schrödinger). (For interpretation of the
this article.)3.2.1. TTRwt:LUT
In the TTRwt:LUT crystal complex, the extra 30OH group of this
ﬂavone is positioned in one of the symmetric HBP3 pockets in theas found in the crystallographic complexes reported here. Only the AC site is shown,
tal structures. The TTRwt aminoacid residues that participate in ligand binding are
red spheres. Atoms participating in polar interactions are connected by dashed lines.
Two ligand symmetric copies were modeled as a consequence of the two fold axis
igand molecule found at the AC site was superposed with the ligand molecule found
ide of each ﬁgure. Oxygen and nitrogen atoms are colored red and blue, respectively.
references to colour in this ﬁgure legend, the reader is referred to the web version of
Fig. 3. Stereo view of the TTRwt:KAE (A) and TTRwt:NAR (B) binding sites, as found in the crystallographic complexes reported here. The AC site is shown in the upper panels.
The TTRwt aminoacid residues that participate in ligand binding are shown as sticks and labeled. Water molecules that participate in binding or were retained after ligand
binding are displayed as red spheres. Atoms participating in polar interactions are connected by dashed lines. The ligand is shown as sticks, contoured by the calculated omit
map (2Fo–Fc) at r = 0.5. Two ligand symmetric copies were modeled as a consequence of the two fold axis cross the binding site vertically. The symmetric ligand copy is
shown as grey sticks. The ligand molecule found at the AC site was superposed with the ligand molecule found at the BD site of each crystal complex (in black). This
superposition is shown in the right side of each ﬁgure. Oxygen and nitrogen atoms are colored red and blue, respectively. Figures were generated using the Pymol software
(Schrödinger). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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chains. As a consequence, and different from the observed in the
majority of TTRwt:ligands crystal structures, the Ser117 and
Thr119 side chains in the TTRwt:LUT complex display only one
well deﬁned conformation, with their hydroxyl groups turned to
the ligand. This is probably due to the fact that the LUT 30OH group
is positioned very closely to a crystallographic water molecule,
which is oriented by the Ser117 and Thr119 side chains and is gen-
erally found in apoTTRwt crystal structures. Depending on the
symmetric ligand position this water molecule is released to
accommodate the LUT 30OH group, which in turn maintains the
Ser117 and Thr119 side chain conformation by maintaining the
above mentioned hydrogen bonds. It is important to mention that
this water molecule has occupancy of 0.5.
Superimposing the TTRwt:LUT crystal structure with the
TTRwt:GEN crystal complex (Trivella et al., 2010) we observed that
LUT binds shallower than GEN. As a consequence, the LUT 40OH
group is not able to perform hydrogen bonds with Ser117 side
chains as observed for GEN. Instead, a water molecule is retained
between the symmetric Ser117 side chains in the bottom of the
TTRwt:LUT binding sites. This central water molecule is at ideal
distances to form a hydrogen bond with the LUT 40OH group as
shown in Fig. 2A.
At the entrance of the TTRwt:LUT binding sites the LUT hydro-
xyl groups of its AC rings cannot form interactions with the Nz
atom from Lys15 side chain. On the contrary, the Lys15 side chains
are found in a single conformation, with the Nz atoms turned out-
wards from LUT, and only hydrophobic interactions between LUT
and TTRwt are observed.
We were unable to identify the differences between the two
binding sites of the TTRwt:LUT crystal complex by comparing
either the ligand or the TTRwt atomic positions.3.1.2. TTRwt:API
API binds TTRwt in a very similar fashion to LUT, with the main
differences between the two complexes concentrated at the bot-
tom part of the TTRwt binding site (Fig. 2B). However, API does
not have a hydroxyl group attached to its 3’ position and for this
reason direct hydrogen bonds between the ligand and the Ser117
and Thr119 TTRwt side chains are not observed. On the contrary,
these side chains are very ﬂexible and at least two well deﬁned
rotamers for Ser117 and Thr119 could be modeled in the twoTTRwt:API binding sites. The central water molecule observed in
the TTRwt:LUT crystal structure is also found in the TTRwt:API
structure, suggesting that the API 40OH group can form a hydrogen
bond with this crystallographic water, similarly to the observed for
TTRwt:LUT complex.3.1.3. TTRwt:KAE
KAE displays an additional 3OH substituent, characteristic of
ﬂavonols (Fig. 1), although direct contacts between the KAE 3OH
group and TTRwt residues were not observed. However, the 3OH
substitution interferes with ﬂavonol binding to TTRwt, since differ-
ently from what is observed for the TTRwt:LUT and TTRwt:API
crystal complexes, signiﬁcant differences in the interaction of
KAE with the AC and BD sites of TTRwt were veriﬁed. The KAE li-
gand binding to TTRwt results in a different number, type and dis-
tances of protein:ligand interactions, as well as water release/
retention, between the two sites of TTRwt:KAE crystal complex.
In the AC site, KAE is positioned in a very similar fashion to the
observed in the TTRwt:API and TTrwt:LUT crystal complexes, and
this ﬂavonol performs basically the same interactions with TTRwt
as the ﬂavone API. KAE forms apolar interactions with Lys15 side
chains at the entrance and polar contacts with a water molecule
at the bottom of the AC binding cavity (Fig. 3A). In addition to
the apolar contacts formed with the Lys15 side chain, only Leu17
was found to contribute to KAE stabilization at the AC cavity of
TTRwt:KAE crystal complex.
On the other hand, in the BD cavity KAE is displaced in direction
of the center and bottom of the binding site. As a consequence, the
strong apolar interactions, found between KAE and Lys15 side
chains at the entrance of the AC channel, are disallowed in the
BD cavity (interatomic distances >5 ÅA
0
) and ordered water mole-
cules are retained at the entrance and at the center of this channel.
However, KAE is still in contact with a crystallographic water mol-
ecule coordinated by Ser117 and Thr119 side chains at the bottom
of the BD site, as found in the AC channel. Leu17, Leu110 and
Ala108 also contribute to KAE stabilization at the BD channel
through hydrophobic interactions.
It is also important to note that only one Ser117 side chain con-
formation was observed in the two TTRwt:KAE binding sites. How-
ever, as observed to LUT and API, the distances between the 40OH
from KAE and the OG atom from Ser117 side chain are long
(>3.6 ÅA
0
), thus suggesting limited hydrogen bond formation.
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CHR does not possess hydroxyl groups attached to its B ring
(Fig. 1). As a consequence, it is not able to contact the bottom por-
tion of the TTRwt binding site by polar contacts, as observed for
LUT, API and KAE. Instead, hydrophobic interactions dominate
CHR recognition by TTRwt and polar contacts are only found at
the entrance of the channel (Fig. 2C). The B ring of CHR binds deep
into the TTRwt binding site, being inserted into HBP3, contacting
Ser117, Thr119 and Leu110 through hydrophobic interactions.
The A and C rings are displaced, positioning the CHR 70OH group
at the ideal distance to form a polar contact with the Nz atom from
one of the Lys15 side chains found at the entrance of the TTRwt
binding cavity. Hydrophobic interactions are also found between
the AC rings from CHR and TTRwt residues located at the center
(Leu17, Ala108) and at the entrance (Lys15) of the binding cavity.
CHR position is virtually identical in the two TTRwt:CHR binding
sites and it was not possible to ﬁnd different conformations
adopted by TTR residues by comparing the two binding sites in this
crystal complex. However, the distances between the atoms in-
volved in apolar contacts are increased in the AC binding cavity,
what can negatively contribute to ligand afﬁnity in this site.
3.1.5. TTRwt:NAR
NAR is very similar to API in terms of hydroxyl group number
and position. However, NAR is a ﬂavanone and, therefore, does
not possess the C ring double bond, thus permitting a higher de-
gree of freedom for the atoms that compose this ring. NAR binding
position is displaced within the two sites of TTRwt (Fig. 3B) in com-
parison to the other ﬂavonoids analyzed in the present work
(including GEN). As a consequence, water molecules are retained
within the binding site and at its surrounding.
The electron density for the NAR B ring is very fragmented in
the AC channel of our TTRwt:NAR crystal complex. Therefore, there
are uncertainties in NAR B ring position at the AC channel of
TTRwt. However, at the BD channel it was possible to securely
model position of the B ring. The NAR B ring is found inserted into
the HBP3 of the BD channel, displacing Ser117 and Thr119 side
chains to accommodate the ligand and optimize apolar contacts
with the hydrophobic portion of these amino acid side chains.
The NAR 4 OH group can contact a water molecule positioned be-
tween the two symmetric Ser117 side chains at the bottom of the
BD cavity.
The very well deﬁned electron density for NAR A and C rings al-
lowed us to model with precision the position of this portion of the
ligand in both binding channels of TTRwt:NAR crystal complex. At
the entrance of the binding channels, NAR is displaced in the AC in
comparison to the BD site (Fig. 3B). As a result, the interactions
performed by NAR with TTRwt at the BD channel are more favor-
able for binding than the interactions observed at the AC site. In
the AC site, the hydroxyl groups attached to NAR in the position
5 and 7 contact directly the side chains of Lys15 from both A
(3.2 ÅA
0
) and C (3.0 ÅA
0
) subunits from TTRwt. However, in the BD site,
the NAR 7 OH group is placed exactly between the two Lys15 side
chains, contacting the Nz atoms from Lys15 at identical distances
(2.7 ÅA
0
). It is important to comment that the 7 OH from ﬂavonoids
is the hydroxyl group with higher propensity to deprotonation –
as calculated in the Sparc server (SPARC, 2010). In this context,
the position of NAR at the TTRwt BD channel suggests the forma-
tion of electrostatic interactions between the substituent at posi-
tion 7 (O) from NAR and the Lys15 side chains. Water
molecules are observed at the entrance of the BD channel, and
these are in ideal distances to perform hydrogen bonds with NAR
via the 5 and 7 oxygen atoms. Hydrophobic contacts between
NAR and TTRwt residues Lys15, Leu17, Ala108 and Leu110 are also
suggested by LigPlot analysis, however these contacts were found
at the shorter distances and in a higher number in the BD channel.4. Discussion
4.1. Comparative analysis of ﬂavonoid binding to TTRwt
Flavonoid molecules can explore the bottom, center and en-
trance of TTRwt binding channels, by using different strategies,
depending on the position and type of substituents placed in each
portion of TBS. By superposing the ﬂavonoids found in the binding
sites of each TTRwt crystal complex reported here one can better
identify the diversity of binding modes and interactions above de-
scribed and correlate these differences with chemical-structural
modiﬁcations in the ligand.
As has already been reported, polar contacts at the entrance and
bottom of TBS are very important for inhibitor recognition (Adam-
ski-Werner et al., 2004; Klabunde et al., 2000). From our data, di-
rect interactions with Ser117 correlate with higher afﬁnity and
enthalpy of binding. GEN (Kd1 40 nM (Trivella et al., 2010)) and
LUT (Kd = 100 nM) both display high afﬁnity to TTRwt and perform
direct interactions with Ser117. On the other hand, CHR, lacking
the 4OH group, does not perform such interactions and has low
afﬁnity to TTRwt. Furthermore, as compared to LUT, KAE and API
both show lower enthalpic contribution in binding to TTRwt and
neither of these ligands directly interact with Ser117. Similar
observations were also performed to diﬂunisal (DIF) analogues
when binding to TTR, where the high afﬁnity analogue showed
interactions with Ser117, whereas DIF and other lower afﬁnity ana-
logues bound to TTR in the ‘‘forward’’ mode (Adamski-Werner
et al., 2004), lacking direct polar contacts with Ser117.
Interactions with Lys15 and Glu54 side chains at the entrance of
the cavity were also reported to increase TTR binding afﬁnity (Triv-
ella et al., 2011; Wojtczak et al., 1996). The natural ligand T4, for
example, performs strong interactions with both Lys15 and Glu54
side chains in one of the binding cavities, displaying nanomolar
afﬁnity to the ﬁrst TTRwt binding site. However, in the second bind-
ing site one of these interactions is lost, which has been suggested
as one of the main reasons for the low binding afﬁnity of the second
ligand to TTRwt. Similar observationswere performedwith the syn-
thetic T4 analogues GC-1 and GC-24, that lack the amino group in
the side chain (Trivella et al., 2011). The GCs displayed indirect
interactions with Lys15 and no interactions with Glu54, resulting
in micromolar afﬁnity to the two biding sites of TTRwt.
Our combined structural and thermodynamic data for TTR
ﬂavonoids binding suggest that interactions with Lys15 side chain
probably contribute to the enthalpic gain; however, in this case the
entropy compensation may compromise binding afﬁnity to TTRwt.
NAR and CHR, for example, form polar contacts with Lys15 side
chains and presented favorable enthalpic contribution of binding
to TTRwt. However, the low binding constants obtained by ITC sug-
gest large unfavorable entropy compensation for binding.
Even hydrophobic interactions with Lys15 may be favorable to
binding to TTRwt. As observed to LUT, API and KAE (AC site), the
AC rings from these ﬂavonoids are oriented by the Lys15 side
chains at the entrance of the TTRwt TBS. The later interaction
may guide ligand position on the center and bottom of the TTRwt
binding site. If the interaction with Lys15 is loose, as observed for
KAE binding at the BD channel, the ligand can be miss oriented
reducing its afﬁnity to TTRwt.
We observed signiﬁcant differences in ﬂavonoids position at the
center of the TTRwt binding cavity. It is important to mention that
this region is the narrowest portion of the TTRwt binding site. CHR
and NAR are displaced at the center of the cavity, with their AC
fused rings at this region (near Ala108). The additional KAE 3OH
group and the GEN carbonyl group at 4 position and the hydroxyl
group at 5 position all occupy the center of TTRwt binding sites. On
the other hand, LUT and API poorly explore this portion of the cav-
ity (Fig. S2), with their AC rings inserted into HBP1.
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As suggested by crystallographic and ITC analyses, the ﬂavo-
noids studied here interact with TTRwt by distinct mechanisms
of binding. Our experimental data allowed us to determine their
most probable mechanisms of interaction to TTRwt, as well as to
evaluate the molecular basis of cooperativity between the two sites
of TTRwt when binding ﬂavonoids.
No differences in ligand or in TTR residues conformation were
observed by superposing the AC with the BD channel of the
TTRwt:LUT or TTRwt:API crystal complexes, giving support to the
‘‘identical and independent’’ binding mechanism of API and LUT
to TTRwt, as deducted from ITC experiments.
However, for KAE binding our ITC experiments suggested two
possible mechanisms of interaction: the ‘‘identical and indepen-
dent’’ or the ‘‘sequential’’ binding mode. The TTRwt:KAE crystal
structure clearly shows that KAE binds differently to the two TBS
of TTRwt (Fig. 3A), supporting the ‘‘sequential’’ binding mode. Fur-
thermore, the IC50 value obtained from the TTRwt acid mediated
aggregation curves with KAE (IC50 KAE = 8.26 ± 1.06) was very sim-
ilar to the IC50 found to GEN (IC50 GEN = 8.11 ± 1.07 lM). Therefore,
it is most probable that KAE displays similar binding constants to
GEN for at least one TBS (Kd1 GEN  30 nM (Green et al., 2005; Triv-
ella et al., 2010)). This is again the case for the ‘‘sequential’’ binding
mode, when the TTRwt:KAE Kd value retuned by the adjustment of
TTRwt:KAE ITC curves is in the nanomolar range (Kd1 KAE = 180 ±
50 nM – Table 4).
The ligand position and contacts found for KAE at the AC
TTRwt:KAE biding site are very similar to the ones observed in
the TTRwt:API and TTRwt:LUT crystal complexes. This binding
mode corroborates with the Kd1 values found to LUT, API and
KAE1, all in the nanomolar range. The enthalpic contribution to
KAE binding to TTRwt is in the same range as the values found to
API interaction with TTRwt, that is in harmony with the very sim-Fig. 4. TTRwt binding site modulation induced by ﬂavonoid interaction. (A) The apoTT
indicate the direction of the induced movement. (C) Binding site cavity volume calculated
calculations were performed using the CastP web server. The crystal structures of apoTTR
were used in these analysis.ilar types and distances of the contacts found in the TTRwt:API and
TTRwt:KAE (AC site). However, the ﬁrst KAE binding site displays
more favorable entropy contribution than API, resulting in higher
TTRwt binding afﬁnity to KAE (ﬁrst binding site) than API (Table 4).
This suggests that the entropic gain observed for KAE is a conse-
quence of the 3OH substituent attached to the KAE C ring (typical
for ﬂavonols), which forces the protein to adjust its binding site for
ligand accommodation, generating movements that may account
for the entropy of binding.
The KAE 3OH group is positioned at the central portion of the
TTRwt binding cavity, near to the narrowest portion of the channel
(Figs. 3A and 4B). We measured the binding cavity volumes and
movements induced by ligand binding in all the TTRwt:ﬂavonoid
crystal structures reported here. As illustrated in Fig. 4, KAE binding
to TTRwt generates an enlargement of the binding channels, with
major contribution from the center of the cavity. Since thedifference
between API and KAE is only the 3OH substitution, and this portion
of KAE is placed at the center of the TTRwt cavity, this implies that
the accommodation of the KAE 3OH group into the TTRwt binding
cavitymay need adjustment of the protein in order to accommodate
the ligand. As a result, allosteric movements may inﬂuence the sec-
ond binding event, affecting the second KAE molecule interactions
with TTRwt, as indeed observed in our experiments.
In the low afﬁnity TTRwt:KAE binding site the enthalpic and
entropic contribution are less favored (Table 4). The interaction be-
tween KAE and the Lys15 side chains at the entrance of the BD
channel are disallowed, and water molecules are retained at the
entrance and center of the TTRwt:KAE BD channel. Together, the
two latter events contribute negatively to binding enthalpy and en-
tropy in the low afﬁnity TTRwt:KAE interacting site, as suggested
by the thermodynamic parameters retuned by the ITC analysis in
the ‘‘sequential’’ binding mode (Table 4).
For CHR, the thermodynamic parameters returned with the two
mathematical models used are very similar (Table 4). The bindingRwt binding site. (B) Binding sites of TTRwt binding different ﬂavonoids, arrows
from the different crystal structures of TTRwt in the apo form or biding ﬂavonoids,
wt (PDB ID 3CFM), TTRwt:GEN (PDB ID 3KGU) and TTRwt:ﬂavonoids reported here
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are concentrated in more favorable enthalpy in the ‘‘sequential’’
binding model, compensated by unfavorable entropy of binding.
Therefore, binding of the ﬁrst CHR molecule to TTRwt, does not
inﬂuence very much the second binding site interactions with this
ﬂavone. As can be observed in Fig. 4, the binding of CHR to TTRwt
results in collapse of the biding site, more evident at the BD chan-
nel. As a consequence, the hydrophobic interactions at the BD
channel are favored and may, therefore, contribute positively to
the enthalpy of biding.
The analysis of the TTRwt:NAR crystal complex pointed the dif-
ferences between NAR interaction with the two sites of TTRwt,
including: (1) different atoms from the ligand involved in contacts
with Lys15, (2) different types of interaction with Lys15, (3) longer
distances between protein and ligand atoms at the AC site and dif-
ferent accommodation/ﬂexibility of NAR B ring. The adjustment of
the ITC curves of NAR interaction with TTRwt by the ‘‘sequential’’
binding mode show similar enthalpic contribution for NAR binding
to the two TTRwt binding sites (10 kcal mol1), however the
entropic contribution for the ﬁrst binding site is more favorable
(TDS1 = 1.96 kcal mol1, TDS2 = 3.36 kcal mol1). The main dif-
ferences observed between the two biding sites of the TTRwt:NAR
crystal complex were the weaker interactions of Lys15 with the li-
gand at the entrance and the ﬂexibility of the B ring at the bottom
of TTRwt binding sites. As ligand binding induced decreased ﬂexi-
bility is a well known factor contributing negatively to binding en-
tropy, we propose that the insertion and stabilization of the NAR B
ring into TTRwt HBP3 is one of the main reasons for unfavorable
NAR entropy of binding to the second (BD) channel of TTRwt.
The binding site movements and volume in each TTRwt:ﬂavo-
noid crystal complex were analyzed in comparison to the apo-
TTRwt crystal structure (Figs. 4 and S3). From these analysis it is
observed that in all TTRwt:ﬂavonoid crystal complexes the binding
site is modulated acquiring a complementary shape to the ligand,
optimizing the protein:ligand interactions and ligand accommoda-
tion (Fig. 4). Main chain movements are more pronounced at the
center of the binding channel (residue 108–109) as one can ob-
serve in Fig. S3. Comparison of the binding sites surfaces also indi-
cates that the strongest changes are concentrated at the middle of
TBS. Therefore, the movements at the binding site center are prob-
ably inﬂuenced by main chain movements, whereas movements at
the binding site entrance and bottom are more related to side chain
ﬂexibility.
In TTRwt:KAE the center of the binding cavity is enlarged prob-
ably as a result of the 3OH accommodation. As CHR and NAR bind
deep into TTRwt binding sites, the polar interactions with Lys15 at
the entrance are favored and the side chains from Lys15 close and
modify the entrance of the cavity. Although NAR and CHR fused AC
rings are positioned at the center of TTRwt binding cavity, the
enlargement of the binding site in this region was not observed. In-
stead, a movement of protein residues in the direction of the li-
gand, resulting in reduced binding site volume, was observed in
the TTRwt:CHR TBS (Fig. 4). In the TTRwt:NAR complex similar
adjustments were observed, however, in this case, the binding site
was enlarged diagonally, resulting in enhanced binding site vol-
ume (Fig. 4).
Ligands that insert their large and bulky portions at the center
of TTRwt cavity force the binding site to expand. In the case of
KAE and NAR, the main chains of TTRwt residues placed at the en-
trance and bottom of the cavity participate in such adjustments.
However, in the case of GEN, which binds deep into the cavity,
the main protein movements for ligand accommodation are con-
centrated and are probably transmitted to the second binding site
through the bottom portion of the cavity.
With the exception of API and LUT, all other ﬂavonoids analyzed
in the current study show cooperativity between the two sites ofTTRwt (GEN:40-fold (Trivella et al., 2010), KAE: 20-fold, NAR: 10-
fold). Our crystal structures of TTR complexes with these ligands
reveal that all ‘‘cooperative’’ ligands show differences in their bind-
ing to the two TTRwt TBS and/or loss of protein:ligand contacts in
the low afﬁnity binding cavity. Depending on the type and contri-
bution to biding, the allosteric modiﬁcations caused by the ﬁrst li-
gand interaction with TTRwt can result in neutral or more
pronounced effects to the second ligand binding event. In
TTRwt:GEN (Trivella et al., 2010) the rotation of Ser117 side chain
is the protagonist of the ‘‘sequential’’ binding mode and shows fun-
damental participation to TTR interaction with GEN. The deep
binding position of GEN into the bottom of the cavity may facilitate
the Ser117 rotation at the bottom of the second biding site, since
the bottom of the two binding sites are close disposed and sepa-
rated by a core of water molecules in the center of TTR tetramer.
For KAE and NAR, the ﬁrst ligand binding event may modify the
shape and volume of the second site, resulting in the displacement
of the ligand in the central region of the second binding cavity (BD
site), modifying its recognition by TTR. CHR collapses the TTRwt
binding sites and this movement is less pronounced in the AC site
(the probable low afﬁnity binding site). It is proposed that the
movements induced by CHR to TTRwt are reduced if one binding
site is already occupied by the ligand, resulting in small loss of bid-
ing afﬁnity due to larger distances in protein:ligand hydrophobic
contacts.
API and LUT do not show cooperativity of biding to the two sites
of TTRwt. API and LUT position into the two sites of TTRwt are the
same, as well are the protein:ligand contacts. The shape and vol-
ume of the two binding sites are also very similar to each other
and to the apoTTRwt. Therefore, the allosteric movements induced
by the ﬁrst API/ LUT molecule to TTRwt does not affect the second
ligand binding event, characterizing an independent binding mode.
This is probably due to API and LUT accommodation into HBP1 as
well as the absence of the 3OH group (present in KAE). As a conse-
quence, these ﬂavones bind shallower – not affecting the bottom of
the channel – and do not disturb the narrowest and ﬂexible center
of the TTRwt binding site.
In summary, we propose that ﬂavonoids that accommodate at
the central portion of the binding cavity are more susceptible to
the effects of conformational changes induced by the ﬁrst ligand
binding event with the TTR tetramer, which are transmitted into
the second ligand binding site (as observed to KAE and NAR) and
may result in loss of protein:ligand interactions (GEN, KAE, CHR
and NAR).
4.3. Implications for ﬂavonoids binding to the TTR V30M mutant
As presented in Table 3, the ﬂavonoids analyzed here, with the
exception of LUT and API, show decreased potency in inhibiting the
V30M mutant TTR aggregation in vitro. As mentioned above, KAE,
NAR, GEN and CHR position their AC fused rings, or substituents at-
tached to them, in the narrowest portion of the TTR binding cavity.
When analyzing the differences between the wild type and V30M
mutant TTR (Trivella et al., 2010) we demonstrated that the central
portion of the V30Mmutant binding cavity is rather narrower than
the wild type cavity. The V30M mutation is placed just behind
Ala108, forcing Ala107–Ala109 to move towards the center of the
cavity. In addition to the induced reentrance, the V30M mutation
may also reduce the movements in the central portion of the
V30M mutant TBSs, limiting ligand accommodation into the
V30M binding sites.
Fig. S2 shows the superposition of the ﬂavonoids – as found in
the TTRwt:ﬂavonoid crystal structures reported here – with the
apoV30M binding site. This superposition indicates that KAE,
NAR and CHR probably face steric restrictions or less favorable
accommodation to the central region of the V30M binding cavity.
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experiments to check for V30M binding to these ﬂavonoids. As one
can observe in Fig. S4, CHR, KAE and NAR isotherms indicate weak-
er binding to the V30M mutant (less pronounced in KAE and very
clear to NAR and CHR). In the mutant isotherms the slope and the
overall heat of interaction (y axis), indicate decreased binding
afﬁnity and enthalpy of binding, respectively.
Based on crystal structure superposition and ITC data, we advo-
cate that ﬂavonoids with their AC rings positioned in the center of
the TTRwt cavity will have steric restrictions to being accommo-
dated within the V30Mmutant binding sites, due to their narrower
central cavity as well to their lower ﬂexibility due to the bulky
V30M mutation. Therefore, ligand accommodation and interaction
with the V30M mutant sites is probably the main reason for the
low potency observed to KAE, NAR and CHR in inhibiting the
V30M mutant TTR acid mediated aggregation.5. Conclusions
In the present study we tested and characterized in details the
interaction of different ﬂavonoids with TTR. For this we selected
ﬂavonoids from the ﬂavone, ﬂavanone and ﬂavonol families and
compared the results of their binding to TTR with those already re-
ported for the isoﬂavone genistein (Trivella et al., 2010). Although
the chemical structures of the tested ﬂavonoids are similar, the
small chemical and structural differences between them result in
distinct wild type and V30M mutant aggregation inhibition, ligand
accommodation and protein:ligand interactions, mechanisms of
binding and thermodynamic signatures of binding to TTRwt bind-
ing sites. These differences are probably a consequence of the B
ring position (attached at position 3 of the isoﬂavone GEN and at
position 2 in the other ﬂavonoids), the ﬂexibility of the C ring (in
NAR) and the presence of 40OH group (absent in CHR) or the 3OH
group (present in ﬂavonols such as KAE).
The B ring was found placed centrally at the bottom of the bind-
ing site binding deep (GEN), less inserted (API, LUT and KAE) or dis-
located and inserted into the HBP3 (CHR and NAR). As a
consequence, the fused AC rings could occupy the HBP1, the cen-
tral region or dislocated at the central region of the cavity.
Ligand accommodation at the central region of the cavity seems
to inﬂuence signiﬁcantly the biding to the V30M mutant. All the
ﬂavonoid tested, with API and LUT exception, accommodates rigid
and voluminous substituents at the narrowest portion of the bind-
ing cavity (between HBP1 and HBP2). This region is considerably
narrower in the V30M mutant. Therefore there is a correlation be-
tween the accommodation of rigid and bulky substituents at the
central portion of the cavity and the weakness of V30M binding.
These results may originate from the narrowest V30M cavity or
from the loss in binding site ﬂexibility in the V30Mmutant binding
cavity, resulting in steric restrictions for ligand accommodation.
With the exception of API and LUT, all other ﬂavonoids showed
cooperativity between the two binding sites of TTRwt. The crystal
structure analyses of TTRwt binding ﬂavonoids suggest that all
ﬂavonoids generate movements to the TTRwt tetramer upon bind-
ing. However, the effects of these movements on the ligand inter-
actions with the second TTRwt binding cavity were only observed
to ligands that accommodate voluminous portions in the central
region (KAE, NAR, CHR, GEN) and are maximized in the case of
GEN, which interact with the bottom of the binding cavity.
Depending on the mode of ligand interaction (ideal position in
the binding site, type and position of interactions with TTRwt)
the differences between the two sites may be enhanced (GEN,
KAE and NAR), reduced (CHR) or absent (API and LUT).
It is difﬁcult to determine the exact pathway by which changes
in the size and form of the ﬁrst binding site are inﬂuencing the sec-ond binding site, since more than one type of induced movement
can occur at the same time depending on the ligand. By analysis
of the crystal structures reported in the present study and the pre-
viously published structures, available in PDB, we can suggest
three main types of ligand induced TTR movements:
(1) Transmission through the bottom of the channels: if the ligand
binds deep into the ﬁrst binding site – as in the case of GEN –
it can inﬂuence the organization of water molecule network
at the tetrameric center (in the space between the bottom of
the two binding sites), what in turn can alter the conforma-
tion of binding site residues such as Ser117 and Thr119 in
the bottom of the second channel, and therefore alter ligand
afﬁnity.
(2) Transmission trough the inner b-sheets: We observed that the
central region of the TTRwt binding site is ﬂexible and can be
modulated by ligands that position rigid and bulky groups in
the central region of the channel (as was observed for the
ﬂavonoids KAE, CHR, NAR and as was reported for T4 (Trivel-
la et al., 2011; Wojtczak et al., 1996)). The ﬂexibility of the
central region of TTRwt is probably due to the binding chan-
nels being formed by the inner b-sheets of TTR monomers,
providing space for protein modulation in between the inner
and outer sheets, as well as the binding site itself. This may
facilitate the inner sheet to undergo modulation upon ligand
binding, thus modifying the binding site shape and ligand
accommodation. These movements were partially probed
by analyzing the interactions of KAE, CHR and NAR with
the V30M mutant. If the Met30 mutation is present, the
bulky Met substitution – localized between the inner and
outer sheet – probably limits the central region movements,
restricting binding site modulation and ligand accommoda-
tion, and therefore the ligands that place their large and
voluminous portions in the central region of the channel
would display limited binding to the V30M mutant, as we
report in the present work. In the case of ligand binding
induced protein modulation, these movements may be
transmitted to the second channel through the dimer inter-
face or by modulating protein dynamics after the ﬁrst ligand
binding event;
(3) transmission induced by tight interactions with the entrance of
the binding cavity (Lys15 and Glu54): By analyzing the T4 and
GCs interactions with TTR (Trivella et al., 2011), we also
observed that tight interactions with Lys15 and/or Glu54
may be involved in protein movements that could be trans-
mitted to the second channel through movements in the
whole tetramer. In this case the interactions with the
entrance of the ﬁrst binding site could ‘pull’ the residues in
the direction of closing the ﬁrst binding site entrance, and
opening the second channel entrance. However, it is not
clear if these movements are induced by ligand contacts
with the entrance, with the central region of the ﬁrst TBS
or both.
Overall, the data presented here allow for a deeper comprehen-
sion of the molecular mechanisms of TTR binding to ligands, and
might be useful for further TTRwt and V30M mutant TTR inhibitor
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